Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy

BACKGROUND: The optimal dose of radioactive iodine (RAI) therapy for N1b papillary thyroid carcinoma (PTC) is controversial. We evaluated the clinical outcome of N1b PTC patients treated with either 100 or 150 mCi of RAI. METHODS: We retrospectively analyzed N1b PTC patients who underwent total thyr...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Endocrinol Metab (Seoul)
Hoofdauteurs: Jin, Meihua, Ahn, Jonghwa, Lee, Yu-Mi, Sung, Tae-Yon, Kim, Won Gu, Kim, Tae Yong, Ryu, Jin-Sook, Kim, Won Bae, Shong, Young Kee, Jeon, Min Ji
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Korean Endocrine Society 2020
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7520585/
https://ncbi.nlm.nih.gov/pubmed/32981302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2020.741
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items